ArticlePharmaceuticals (Basel, Switzerland)2024

Structure-Based In Silico Approaches Reveal IRESSA as a Multitargeted Breast Cancer Regulatory, Signalling, and Receptor Protein Inhibitor.

Hassan Hussain Almasoudi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.